Onxeo to present at InvestorDagen 2015

Onxeo to present at InvestorDagen 2015

The largest Danish private investor event

September 22, 2015, Radisson Blu Scandinavia Hotel, Copenhagen

Onxeo S.A. (Euronext Paris, NASDAQ Copenhagen: ONXEO), an innovative biopharmaceutical company specialized in the development of drugs for orphan oncology diseases, will be presenting at InvestorDagen 2015, which will be held in Copenhagen, Denmark on September 22, 2015 at the Radisson Blu Scandinavia Hotel.

InvestorDagen is hosted by the Danish Shareholders’ Association (Dansk Aktionærforening), an association with 12,000 members. With around 2,500 participants each year, InvestorDagen is the largest event for private investors in Denmark.

Onxeo’s Chief Financial Officer, Nicolas Fellmann, will give a presentation of the Company, its key strengths, its strategy based on advanced orphan oncology products, and the mid-term news flow, which is expected to drive the company’s value and future growth. You will furthermore be able to meet face-to-face with representatives from the company’s management team at the Onxeo stand.